Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Cortisone in Popular Culture: Roueché, Ray, and Hench.

Wijdicks EFM, Rooke TW, Hunder GG, Dacy MD.

Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):215-220. doi: 10.1016/j.mayocpiqo.2019.04.003. eCollection 2019 Jun. Review.

2.

Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature.

Salvarani C, Brown RD Jr, Muratore F, Christianson TJH, Galli E, Pipitone N, Cassone G, Huston J III, Giannini C, Warrington K, Hunder GG.

Autoimmun Rev. 2019 Apr;18(4):399-405. doi: 10.1016/j.autrev.2018.12.002. Epub 2019 Feb 10. Review.

PMID:
30743080
3.

Primary central nervous system vasculitis mimicking brain tumor: Comprehensive analysis of 13 cases from a single institutional cohort of 191 cases.

Salvarani C, Brown RD Jr, Christianson TJH, Huston J 3rd, Morris JM, Giannini C, Hunder GG.

J Autoimmun. 2019 Feb;97:22-28. doi: 10.1016/j.jaut.2018.10.001. Epub 2018 Oct 24.

PMID:
30528173
4.

Primary central nervous system vasculitis associated with lymphoma.

Salvarani C, Brown RD Jr, Christianson TJH, Huston J 3rd, Ansell SM, Giannini C, Hunder GG.

Neurology. 2018 Mar 6;90(10):e847-e855. doi: 10.1212/WNL.0000000000005062. Epub 2018 Feb 2.

PMID:
29429967
5.

Adult Primary Central Nervous System Vasculitis.

Salvarani C, Brown RD Jr, Hunder GG.

Isr Med Assoc J. 2017 Jul;19(7):448-453. Review. No abstract available.

6.

Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.

Maleszewski JJ, Younge BR, Fritzlen JT, Hunder GG, Goronzy JJ, Warrington KJ, Weyand CM.

Mod Pathol. 2017 Jun;30(6):788-796. doi: 10.1038/modpathol.2017.10. Epub 2017 Mar 3.

7.

Predictors of Dissection in Aortic Aneurysms From Giant Cell Arteritis.

Kermani TA, Warrington KJ, Crowson CS, Hunder GG, Ytterberg SR, Gabriel SE, Matteson EL.

J Clin Rheumatol. 2016 Jun;22(4):184-7. doi: 10.1097/RHU.0000000000000381.

PMID:
27219304
8.

Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience.

Salvarani C, Morris JM, Giannini C, Brown RD Jr, Christianson T, Hunder GG.

Medicine (Baltimore). 2016 May;95(20):e3613. doi: 10.1097/MD.0000000000003613.

9.

Management of primary and secondary central nervous system vasculitis.

Salvarani C, Pipitone N, Hunder GG.

Curr Opin Rheumatol. 2016 Jan;28(1):21-8. doi: 10.1097/BOR.0000000000000229. Review.

PMID:
26599380
10.

An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients.

Salvarani C, Brown RD Jr, Christianson T, Miller DV, Giannini C, Huston J 3rd, Hunder GG.

Medicine (Baltimore). 2015 May;94(21):e738. doi: 10.1097/MD.0000000000000738.

11.

In memoriam: L. Emmerson Ward, MD, 1918-2014.

Hunder GG, Matteson EL.

Arthritis Rheumatol. 2015 Apr;67(4):859. doi: 10.1002/art.39023. No abstract available.

12.

Mycophenolate mofetil in primary central nervous system vasculitis.

Salvarani C, Brown RD Jr, Christianson TJ, Huston J 3rd, Giannini C, Miller DV, Muratore F, Hunder GG.

Semin Arthritis Rheum. 2015 Aug;45(1):55-9. doi: 10.1016/j.semarthrit.2015.02.008. Epub 2015 Feb 20.

PMID:
25800827
13.

Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients.

Salvarani C, Brown RD Jr, Christianson TJ, Huston J 3rd, Giannini C, Miller DV, Hunder GG.

Arthritis Rheumatol. 2015 Jun;67(6):1637-45. doi: 10.1002/art.39068.

14.

Catastrophic primary central nervous system vasculitis.

Salvarani C, Brown RD Jr, Morris JM, Huston J 3rd, Hunder GG.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S3-4. Epub 2014 May 15.

PMID:
24854370
15.

Treatment of primary CNS vasculitis with rituximab: case report.

Salvarani C, Brown RD Jr, Huston J 3rd, Morris JM, Hunder GG.

Neurology. 2014 Apr 8;82(14):1287-8. doi: 10.1212/WNL.0000000000000293. Epub 2014 Mar 5.

PMID:
24598711
16.

Unilateral chronic relapsing primary central nervous system vasculitis.

Salvarani C, Brown RD Jr, Morris JM, Huston J 3rd, Hunder GG.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S139-40. Epub 2014 Feb 11. No abstract available.

PMID:
24528778
17.

Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis.

Muratore F, Pipitone N, Hunder GG, Salvarani C.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S86-92. Epub 2013 Oct 4. Review.

PMID:
24129145
18.

Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis.

Salvarani C, Hunder GG, Morris JM, Brown RD Jr, Christianson T, Giannini C.

Neurology. 2013 Oct 29;81(18):1596-603. doi: 10.1212/WNL.0b013e3182a9f545. Epub 2013 Sep 27.

19.

Lumbar interspinous bursitis in active polymyalgia rheumatica.

Salvarani C, Barozzi L, Boiardi L, Pipitone N, Bajocchi GL, Macchioni PL, Catanoso M, Pazzola G, Valentino M, De Luca C, Hunder GG.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4):526-31. Epub 2013 May 28.

PMID:
23739147
20.

Role of imaging in the diagnosis of large and medium-sized vessel vasculitis.

Pipitone N, Versari A, Hunder GG, Salvarani C.

Rheum Dis Clin North Am. 2013 Aug;39(3):593-608. doi: 10.1016/j.rdc.2013.02.002. Epub 2013 Mar 6. Review.

PMID:
23719077
21.

Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.

Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL.

Ann Rheum Dis. 2013 Dec;72(12):1989-94. doi: 10.1136/annrheumdis-2012-202408. Epub 2012 Dec 19.

22.

Clinical features of polymyalgia rheumatica and giant cell arteritis.

Salvarani C, Pipitone N, Versari A, Hunder GG.

Nat Rev Rheumatol. 2012 Sep;8(9):509-21. doi: 10.1038/nrrheum.2012.97. Epub 2012 Jul 24. Review.

PMID:
22825731
23.

Adult primary central nervous system vasculitis.

Salvarani C, Brown RD Jr, Hunder GG.

Lancet. 2012 Aug 25;380(9843):767-77. doi: 10.1016/S0140-6736(12)60069-5. Epub 2012 May 9. Review.

PMID:
22575778
24.

Adult primary central nervous system vasculitis: an update.

Salvarani C, Brown RD Jr, Hunder GG.

Curr Opin Rheumatol. 2012 Jan;24(1):46-52. doi: 10.1097/BOR.0b013e32834d6d76. Review.

PMID:
22157412
25.

Philip S. Hench's rheumatology axiomatic generalizations.

Hunder GG, Griffing L.

J Rheumatol. 2011 Dec;38(12):2664-70. doi: 10.3899/jrheum.110606. Review.

PMID:
22134794
26.

Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis.

Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ.

Semin Arthritis Rheum. 2012 Jun;41(6):866-71. doi: 10.1016/j.semarthrit.2011.10.005. Epub 2011 Nov 25.

27.

Primary central nervous system vasculitis presenting with intracranial hemorrhage.

Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG.

Arthritis Rheum. 2011 Nov;63(11):3598-606. doi: 10.1002/art.30594.

28.

The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.

Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE.

Arthritis Rheum. 2011 Mar;63(3):633-9. doi: 10.1002/art.30155.

29.

Vasculitis of the gastrointestinal tract in chronic periaortitis.

Salvarani C, Calamia KT, Matteson EL, Hunder GG, Pipitone N, Miller DV, Warrington KJ.

Medicine (Baltimore). 2011 Jan;90(1):28-39. doi: 10.1097/MD.0b013e318207231e.

30.

Primary central nervous system vasculitis: Is it a single disease?

Hunder GG, Salvarani C, Brown RD Jr.

Ann Neurol. 2010 Nov;68(5):573-4. doi: 10.1002/ana.22161. No abstract available.

PMID:
21031572
31.

Rapidly progressive primary central nervous system vasculitis.

Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG.

Rheumatology (Oxford). 2011 Feb;50(2):349-58. doi: 10.1093/rheumatology/keq303. Epub 2010 Oct 19.

PMID:
20959356
32.

Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.

Schäfer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ.

Rheumatology (Oxford). 2010 Nov;49(11):2104-8. doi: 10.1093/rheumatology/keq200. Epub 2010 Jul 13.

33.

Rheumatology practice at Mayo Clinic: the first 40 years-1920 to 1960.

Hunder GG, Matteson EL.

Mayo Clin Proc. 2010 Apr;85(4):e17-30. doi: 10.4065/mcp.2009.0701. No abstract available.

34.

Localized vasculitis of the gastrointestinal tract: a case series.

Salvarani C, Calamia KT, Crowson CS, Miller DV, Broadwell AW, Hunder GG, Matteson EL, Warrington KJ.

Rheumatology (Oxford). 2010 Jul;49(7):1326-35. doi: 10.1093/rheumatology/keq093. Epub 2010 Apr 1.

PMID:
20360040
35.

Cancer preceding giant cell arteritis: a case-control study.

Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Ytterberg SR, Matteson EL, Gabriel SE, Warrington KJ.

Arthritis Rheum. 2010 Jun;62(6):1763-9. doi: 10.1002/art.27429.

36.

Malignancy risk in patients with giant cell arteritis: a population-based cohort study.

Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ.

Arthritis Care Res (Hoboken). 2010 Feb;62(2):149-54. doi: 10.1002/acr.20062.

37.

Increase in age at onset of giant cell arteritis: a population-based study.

Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Gabriel SE, Matteson EL, Warrington KJ.

Ann Rheum Dis. 2010 Apr;69(4):780-1. doi: 10.1136/ard.2009.111005. Epub 2009 Oct 22. No abstract available.

PMID:
19854712
38.

Symptomatic lower extremity vasculitis in giant cell arteritis: a case series.

Kermani TA, Matteson EL, Hunder GG, Warrington KJ.

J Rheumatol. 2009 Oct;36(10):2277-83. doi: 10.3899/jrheum.090269. Epub 2009 Sep 15.

PMID:
19755612
39.

Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study.

Warrington KJ, Jarpa EP, Crowson CS, Cooper LT, Hunder GG, Matteson EL, Gabriel SE.

Arthritis Res Ther. 2009;11(2):R50. doi: 10.1186/ar2664. Epub 2009 Mar 31.

40.

Prominent perivascular enhancement in primary central nervous system vasculitis.

Salvarani C, Brown RD Jr, Huston J 3rd, Hunder GG.

Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S111. No abstract available.

PMID:
18799067
41.

Biopsy findings in primary angiitis of the central nervous system.

Miller DV, Salvarani C, Hunder GG, Brown RD, Parisi JE, Christianson TJ, Giannini C.

Am J Surg Pathol. 2009 Jan;33(1):35-43. doi: 10.1097/PAS.0b013e318181e097.

PMID:
18941399
42.

Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels.

Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG.

Medicine (Baltimore). 2008 Sep;87(5):264-71. doi: 10.1097/MD.0b013e31818896e1.

43.

Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.

Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG.

Rheumatology (Oxford). 2008 Nov;47(11):1671-7. doi: 10.1093/rheumatology/ken328. Epub 2008 Aug 27.

PMID:
18753193
44.

Polymyalgia rheumatica and giant-cell arteritis.

Salvarani C, Cantini F, Hunder GG.

Lancet. 2008 Jul 19;372(9634):234-45. doi: 10.1016/S0140-6736(08)61077-6. Review.

PMID:
18640460
45.

Primary CNS vasculitis with spinal cord involvement.

Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG.

Neurology. 2008 Jun 10;70(24 Pt 2):2394-400. doi: 10.1212/01.wnl.0000314687.69681.24.

PMID:
18541872
46.

Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?

Salvarani C, Pipitone N, Boiardi L, Hunder GG.

Ann Rheum Dis. 2008 May;67(5):577-9. doi: 10.1136/ard.2007.086330. No abstract available.

PMID:
18408108
47.

Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome.

Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG.

Arthritis Rheum. 2008 Feb;58(2):595-603. doi: 10.1002/art.23300.

48.

Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment.

Salvarani C, Brown RD Jr, Calamia KT, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG.

Arthritis Rheum. 2008 Feb 15;59(2):291-6. doi: 10.1002/art.23337. No abstract available.

49.

Cervical interspinous bursitis in active polymyalgia rheumatica.

Salvarani C, Barozzi L, Cantini F, Niccoli L, Boiardi L, Valentino M, Pipitone N, Bajocchi G, Macchioni P, Catanoso MG, Olivieri I, Hunder GG.

Ann Rheum Dis. 2008 Jun;67(6):758-61. doi: 10.1136/ard.2007.084723. Epub 2008 Jan 21.

PMID:
18208867
50.

Tumor necrosis factor blocking agents in polymyalgia rheumatica and giant cell arteritis.

Salvarani C, Hunder GG.

Ann Intern Med. 2008 Jan 15;148(2):167-8; author reply 168. No abstract available.

PMID:
18195345

Supplemental Content

Loading ...
Support Center